Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives); By Type (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants); By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

Check Today's Best Price

$3500 Buy Now
The Global Blood Preparation market was approximately valued $41.2 billion at 2018, with a projected CAGR of 4.7% during the forecast period.
  • Market Overview

    The Global Blood Preparation market was approximately valued $41.2 billion at 2018, with a projected CAGR of 4.7% during the forecast period. Blood components are products derived from platelet rich plasma or whole blood. It is a procedure in which one unit of whole blood goes through centrifugation. It is carried out in specialized equipment known as a refrigerated centrifuge.

    Market Dynamics

    The growing demand for blood transfusion amongst emergency departments in hospitals, rise in blood disorders such as thrombocytosis and the snowballing requirement for blood during accidents and surgical procedures are the major factors driving the growth of the global blood preparation market. However, during blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high which may hamper the market from growing. Moreover, the introduction of innovative technologies along with the growing usage of plasma in pharmaceutical industry, and many governments across the globe are focusing on increasing the number of blood donations by applying reimbursement policies, such as monetary incentives for donors is likely to gain significant impetus for the blood preparation market share in the coming years.

    Market Segmentation

    The study provides a crucial view of the blood preparation by segmenting the market based on the product, type, application, and geography. The product segment includes whole blood, blood components, and blood derivatives. Platelet aggregation inhibitors, fibrinolytics, and anticoagulants are the classification of the type segment. By application segment, the segmentation comprises of thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

    Scope of the Global Blood Preparation Market

    By Product

    • Whole Blood
      • Red Cells
      • Plasma
      • Platelets
      • Granulocytes
    • Blood Components
      • Packed Red Cells
      • Frozen Plasma
      • Whole Blood Components
      • Platelet Concentrate
      • Leukocyte Reduced Red Blood Cells
    • Blood Derivative

    By Type

    • Platelet Aggregation Inhibitors
      • ADP Inhibitors
      • Glycoprotein Inhibitors
      • COX Inhibitors
      • Others
    • Fibrinolytics
      • Streptokinase
      • Urokinase
      • Tissue Plasminogen Activator (tPA)
    • Anticoagulants
      • Heparins
      • Direct Thrombin Inhibitors
      • Direct Factor Xa Inhibitors
      • Vitamin K Antagonists

    By Application

    • Thrombocytosis
    • Pulmonary Embolism
    • Infectious Disease
    • Angina Blood Vessel Complications
    • Other Applications

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • France
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Korea
      • Rest of APAC
    • South America
      • Brazil
      • Rest of South America
    • Rest of the World
      • Middle East
      • Africa
    keyboard_arrow_up
  • TABLE OF CONTENTS

    Chapter 1 Introduction
    1.1 Executive Summary
    1.2 Market Definition
    1.3 Market Scope

    Chapter 2 Research Methodology
    2.1 Primary Research
    2.2 Research Methodology
    2.3 Assumptions & Exclusions
    2.4 Secondary Data Sources

    Chapter 3 Market Overview
    3.1 Report Segmentation & Scope
    3.2 Key Market Trends
    3.2.1 Drivers
    3.2.2 Restraints
    3.2.3 Opportunities
    3.3 Porter’s Five Forces Analysis
    3.4 Market Share Analysis

    Chapter 4 Global Blood Preparation Market by Product: Market Size and Forecast, 2018 – 2026
    4.1 Introduction
    4.1.1 Market Size and Forecast
    4.2 Whole Blood
    4.2.1 Market Size and Forecast
    4.2.2 Red Cells
    4.2.2.1 Market Size and Forecast
    4.2.3 Plasma
    4.2.3.1 Market Size and Forecast
    4.2.4 Platelets
    4.2.4.1 Market Size and Forecast
    4.2.5 Granulocytes
    4.2.5.1 Market Size and Forecast
    4.3 Blood Components
    4.3.1 Market Size and Forecast
    4.3.2 Packed Red Cells
    4.3.2.1 Market Size and Forecast
    4.3.3 Frozen Plasma
    4.3.3.1 Market Size and Forecast
    4.3.4 Whole Blood Components
    4.3.4.1 Market Size and Forecast
    4.3.5 Platelet Concentrate
    4.3.5.1 Market Size and Forecast
    4.3.6 Leukocyte Reduced Red Blood Cells
    4.3.6.1 Market Size and Forecast
    4.4 Blood Derivative
    4.4.1 Market Size and Forecast

    Chapter 5 Global Blood Preparation Market by Type: Market Size and Forecast, 2018 – 2026
    5.1 Introduction
    5.1.1 Market Size and Forecast
    5.2 Platelet Aggregation Inhibitors
    5.2.1 Market Size and Forecast
    5.2.2 ADP Inhibitors
    5.2.2.1 Market Size and Forecast
    5.2.3 Glycoprotein Inhibitors
    5.2.3.1 Market Size and Forecast
    5.2.4 COX Inhibitors
    5.2.4.1 Market Size and Forecast
    5.2.5 Others
    5.2.5.1 Market Size and Forecast
    5.3 Fibrinolytics
    5.3.1 Market Size and Forecast
    5.3.2 Streptokinase
    5.3.2.1 Market Size and Forecast
    5.3.3 Urokinase
    5.3.3.1 Market Size and Forecast
    5.3.4 Tissue Plasminogen Activator (tPA)
    5.3.4.1 Market Size and Forecast
    5.4 Anticoagulants
    5.4.1 Market Size and Forecast
    5.4.2 Heparins
    5.4.2.1 Market Size and Forecast
    5.4.3 Direct Thrombin Inhibitors
    5.4.3.1 Market Size and Forecast
    5.4.4 Direct Factor Xa Inhibitors
    5.4.4.1 Market Size and Forecast
    5.4.5 Vitamin K Antagonists
    5.4.5.1 Market Size and Forecast

    Chapter 6 Global Blood Preparation Market by Application: Market Size and Forecast, 2018 – 2026
    6.1 Introduction
    6.1.1 Market Size and Forecast
    6.2 Thrombocytosis
    6.2.1 Market Size and Forecast
    6.3 Pulmonary Embolism
    6.3.1 Market Size and Forecast
    6.4 Infectious Disease
    6.4.1 Market Size and Forecast
    6.5 Angina Blood Vessel Complications
    6.5.1 Market Size and Forecast
    6.6 Other Applications
    6.6.1 Market Size and Forecast

    Chapter 7 Global Blood Preparation Market by Geography: Market Size and Forecast, 2018 – 2026
    7.1 Introduction
    7.1.1 Market Size and Forecast
    7.2 North America
    7.2.1 North America Market Size & Forecast, By Country
    7.2.2 North America Market Size & Forecast, By Product
    7.2.3 North America Market Size & Forecast, By Type
    7.2.4 North America Market Size & Forecast, By Application
    7.2.5 The U.S.
    7.2.5.1 Market Size and Forecast
    7.2.6 Canada
    7.2.6.1 Market Size and Forecast
    7.2.7 Mexico
    7.2.7.1 Market Size and Forecast
    7.3 Europe
    7.3.1 Europe Market Size and Forecast, By Country
    7.3.2 Europe Market Size and Forecast, By Product
    7.3.3 Europe Market Size and Forecast, By Type
    7.3.4 Europe Market Size and Forecast, By Application
    7.3.5 UK
    7.3.5.1 Market Size and Forecast
    7.3.6 Germany
    7.3.6.1 Market Size and Forecast
    7.3.7 France
    7.3.7.1 Market Size and Forecast
    7.3.8 Italy
    7.3.8.1 Market Size and Forecast
    7.3.9 Spain
    7.3.9.1 Market Size and Forecast
    7.3.10 Rest of Europe
    7.3.10.1 Market Size and Forecast
    7.4 Asia-Pacific
    7.4.1 Asia-Pacific Market Size and Forecast, By Country
    7.4.2 Asia-Pacific Market Size and Forecast, By Product
    7.4.3 Asia-Pacific Market Size and Forecast, By Type
    7.4.4 Asia-Pacific Market Size and Forecast, By Application
    7.4.5 India
    7.4.5.1 Market Size and Forecast
    7.4.6 China
    7.4.6.1 Market Size and Forecast
    7.4.7 Australia
    7.4.7.1 Market Size and Forecast
    7.4.8 Japan
    7.4.8.1 Market Size and Forecast
    7.4.9 South Korea
    7.4.9.1 Market Size and Forecast
    7.4.10 Rest of Asia-Pacific
    7.4.10.1 Market Size and Forecast
    7.5 South America
    7.5.1 South America Market Size and Forecast, By Country
    7.5.2 South America Market Size and Forecast, By Product
    7.5.3 South America Market Size and Forecast, By Type
    7.5.4 South America Market Size and Forecast, By Application
    7.5.5 Brazil
    7.5.5.1 Market Size and Forecast
    7.5.6 Rest of South America
    7.5.6.1 Market Size and Forecast
    7.6 RoW
    7.6.1 RoW Market Size and Forecast, By Country
    7.6.2 RoW Market Size and Forecast, By Product
    7.6.3 RoW Market Size and Forecast, By Type
    7.6.4 RoW Market Size and Forecast, By Application
    7.6.5 Middle East
    7.6.5.1 Market Size and Forecast
    7.6.6 Africa
    7.6.6.1 Market Size and Forecast

    Chapter 8 Company Profiles
    8.1 AstraZeneca Co
    8.2 Baxter Healthcare Corp.
    8.3 Bristol-Myers Squibb Co.
    8.4 Celgene Corp
    8.5 GlaxoSmithKline PLC
    8.6 Leo Pharma Inc.
    8.7 Pfizer Inc.
    8.8 Sanofi Aventis
    8.9 Shandong East Chemical Industry Co.

    keyboard_arrow_up
  • Blood Preparation Market Key Players

    • AstraZeneca Co
    • Baxter Healthcare Corp.
    • Bristol-Myers Squibb Co.
    • Celgene Corp
    • GlaxoSmithKline PLC
    • Leo Pharma Inc.
    • Pfizer Inc.
    • Sanofi Aventis
    • Shandong East Chemical Industry Co.
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

You may also like

CLIENTS

SHARE YOUR CART